ALBI grade

You have access
ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma
DAICHI ENOMOTO, KAZUHIRO YAMAMOTO, YUKI MATSUMOTO, ASAMI MORIOKA, TOMOHIRO OMURA, SHOHEI KOMATSU, YOSHIHIKO YANO, TAKUMI FUKUMOTO and IKUKO YANO

Anticancer Research March 2023, 43 (3) 1317-1323; DOI: https://doi.org/10.21873/anticanres.16279
You have access
Predictors of Postoperative Ascites After Hepatic Resection in Patients With Hepatocellular Carcinoma
NORIFUMI HARIMOTO, KENICHIRO ARAKI, NORIHIRO ISHII, RYO MURANUSHI, KOUKI HOSHINO, KEI HAGIWARA, MARIKO TSUKAGOSHI, TAKAMICHI IGARASHI, AKIRA WATANABE, NORIO KUBO and KEN SHIRABE

Anticancer Research August 2020, 40 (8) 4343-4349; DOI: https://doi.org/10.21873/anticanres.14437

Main menu